BASIC INFORMATION
| Strain Name: | BALB/cJGpt-Tnfrsf9em1Cin(hTNFRSF9)/Gpt |
| Strain Number: | T003359 |
| Official Symbol: | Tnfrsf9,TNFRSF9 |
| Strain Strategy: | T003359.BALBc-hCD137 strain info.pdf |
| Official Full Name: | tumor necrosis factor receptor superfamily, member 9,TNF receptor superfamily member 9 |
| Also Known As: | ILA,Ly63,4-1BB,Cd137,CDw137,AA408498,AI325004,A930040I11Rik,ILA,4-1BB,CD137 |
| NCBI Number: | 219423604 |
| Research Areas: | Humanized model,Gene humanization model,Humanization of tumor targets |
| Strain Background: | [N000020] BALB/cJGpt |
| Modification Type: | Knockin (KI) |
| Inventory Status: | Live,Cryopreserved |
| Sale Status: | IF (Available for Distribution) |
| Health Status: | Specific pathogen free (SPF) |
| Publications: | 1. Fc-competent TIGITx4-1BB bispecific antibody exerts potent long-lasting antitumor activity by potentiating CD8+ T cell activity and Fcγ receptor-mediated modulation of the tumor microenvironment. Journal for immunotherapy of cancer (2025) |